|
EP3590949B1 |
18 May, 2022
|
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof
|
Oct, 2031
|
10
| |
|
EP2791160B1 |
02 Mar, 2022
|
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
|
Dec, 2032
|
10
| |
|
EP3682905B1 |
01 Dec, 2021
|
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
|
Oct, 2032
|
10
| |
|
EP3134131B1 |
22 Dec, 2021
|
Nucleic Acid Vaccines
|
Apr, 2035
|
5
| |
|
EP3718565B1 |
27 Apr, 2022
|
Respiratory Virus Vaccines
|
Oct, 2036
|
4
| |
|
EP3625345B1 |
24 May, 2023
|
Modified Messenger Rna Comprising Functional Rna Elements
|
NA
|
2
| |
|
EP3458083B1 |
02 Nov, 2022
|
Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof
|
May, 2037
|
2
| |
|
EP3019619B1 |
25 Aug, 2021
|
Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use
|
Jul, 2034
|
2
| |
|
EP3431485B1 |
30 Dec, 2020
|
Engineered Nucleic Acids And Methods Of Use Thereof
|
Oct, 2031
|
2
| |
|
EP3492109B1 |
04 Mar, 2020
|
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
|
Oct, 2032
|
2
| |
|
EP3359670B2 |
14 Feb, 2024
|
Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs
|
Oct, 2036
|
1
| |
|
EP3324979B1 |
12 Oct, 2022
|
Infectious Disease Vaccines
|
Jul, 2036
|
1
| |
|
EP2922554B1 |
23 Feb, 2022
|
Terminally Modified Rna
|
Oct, 2033
|
1
| |
|
EP3394030B1 |
22 Dec, 2021
|
Compounds And Compositions For Intracellular Delivery Of Agents
|
Dec, 2036
|
1
| |
|
EP3350333B1 |
27 Oct, 2021
|
Polynucleotides Containing A Stabilizing Tail Region
|
Sep, 2036
|
1
| |
